Listed

Tenon Medical, Inc.

TNONNasdaqCIK 1560293HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$1.3mRevenue, Q2 FY2026, three months to 2026-06-30$1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 13, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$1.3mRevenue, Q2 FY2026, three months to 2026-06-30$1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure+126.8% on a year earlier
  • Gross margin63.6%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $814.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Revenue: $1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure+20.2 pts on a year earlier
  • Operating margin−262.2%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Revenue: $1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure+244.3 pts on a year earlier
  • Net margin−316.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Revenue: $1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure+174.3 pts on a year earlier
  • Diluted EPS−$12.35Diluted EPS, Q2 FY2026, three months to 2026-06-30−$12.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure+3.2% on a year earlier
  • Free cash flow−$2.9mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001213900-26-089258. Derived: 6-month figure less the 3-month figure.Capital expenditure: $172.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001213900-26-089258. Derived: 6-month figure less the 3-month figure.Report this figureNo year-earlier figure to compare

Last eight quarters

Full statements
Revenue$1.3mGross margin 63.6%
Diluted EPS−$12.35, Q2 FY2026
Free cash flow−$2.9m, Q2 FY2026
Tenon Medical, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$k887Revenue, Q3 FY2024, three months to 2024-09-30$887.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Report this figure770Revenue, Q4 FY2024, three months to 2024-12-31$770.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Report this figure726Revenue, Q1 FY2025, three months to 2025-03-31$726.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Report this figure564Revenue, Q2 FY2025, three months to 2025-06-30$564.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure1,173Revenue, Q3 FY2025, three months to 2025-09-30$1.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Report this figure1,481Revenue, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Report this figure1,379Revenue, Q1 FY2026, three months to 2026-03-31$1.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Report this figure1,279Revenue, Q2 FY2026, three months to 2026-06-30$1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure
Gross margin%47.1%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $418.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Revenue: $887.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Report this figure45.8%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $353.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Revenue: $770.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Report this figure44.5%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $323.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Revenue: $726.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Report this figure43.4%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $245.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Revenue: $564.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure65.9%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $773.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Revenue: $1.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Report this figure68.7%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $1.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Revenue: $1.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Report this figure68.5%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $945.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Revenue: $1.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Report this figure63.6%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $814.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Revenue: $1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure
Operating margin%(362.5%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Revenue: $887.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Report this figure(412.1%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Revenue: $770.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Report this figure(506.5%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Revenue: $726.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Report this figure(506.6%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Revenue: $564.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure(289.2%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Revenue: $1.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Report this figure(193.5%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Revenue: $1.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Report this figure(237.9%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Revenue: $1.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Report this figure(262.2%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Revenue: $1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure
Net margin%(359.0%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Revenue: $887.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Report this figure(400.9%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Revenue: $770.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Report this figure(498.1%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Revenue: $726.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Report this figure(491.0%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Revenue: $564.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure(284.7%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Revenue: $1.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Report this figure(191.2%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Revenue: $1.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Report this figure(252.1%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Revenue: $1.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Report this figure(316.7%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Revenue: $1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure
Diluted EPS$ per share(3.63)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$3.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Report this figurenot reported (Diluted EPS not reported)1.01Diluted EPS, Q1 FY2025, three months to 2025-03-31$1.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Report this figure(12.76)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$12.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure(0.40)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001213900-25-109961.Report this figurenot reported (Diluted EPS not reported)0.31Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Report this figure(12.35)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$12.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-089258.Report this figure
Free cash flow$k(2,447)Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001213900-25-109961. Derived: 9-month figure less the 6-month figure.Capital expenditure: $104.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001213900-25-109961. Derived: 9-month figure less the 6-month figure.Report this figure(2,814)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Capital expenditure: −$37.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Report this figurenot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)(3,935)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001213900-25-109961. Derived: 9-month figure less the 6-month figure.Capital expenditure: −$111.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001213900-25-109961. Derived: 9-month figure less the 6-month figure.Report this figure(2,416)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Capital expenditure: $192.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001213900-26-035707. Derived: 12-month figure less the 9-month figure.Report this figure(3,016)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Capital expenditure: $56.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001213900-26-057695.Report this figure(2,930)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001213900-26-089258. Derived: 6-month figure less the 3-month figure.Capital expenditure: $172.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001213900-26-089258. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$3.9mGross margin 59.8%
Diluted EPS−$1.70, FY2025
Free cash flow−$11.0m, FY2025
Tenon Medical, Inc., key figures for the last five fiscal years
Line itemUnitFY2021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m0.2Revenue, period not labelled, twelve months to 2021-12-31$160.0k. XBRL concept us-gaap:Revenues. 10-K filed 2023-03-10, accession 0001575872-23-000346.Report this figure0.7Revenue, FY2022, twelve months to 2022-12-31$691.0k. XBRL concept us-gaap:Revenues. 10-K filed 2024-03-29, accession 0001213900-24-028010.Report this figure2.9Revenue, FY2023, twelve months to 2023-12-31$2.9m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-26, accession 0001013762-25-002734.Report this figure3.3Revenue, FY2024, twelve months to 2024-12-31$3.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure3.9Revenue, FY2025, twelve months to 2025-12-31$3.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure
Gross margin%65.6%Gross margin, period not labelled, twelve months to 2021-12-31. gross profit / revenueGross profit: $105.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-10, accession 0001575872-23-000346.Revenue: $160.0k. XBRL concept us-gaap:Revenues. 10-K filed 2023-03-10, accession 0001575872-23-000346.Report this figure(92.8%)Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: −$641.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-29, accession 0001213900-24-028010.Revenue: $691.0k. XBRL concept us-gaap:Revenues. 10-K filed 2024-03-29, accession 0001213900-24-028010.Report this figure42.4%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $1.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-26, accession 0001013762-25-002734.Revenue: $2.9m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-26, accession 0001013762-25-002734.Report this figure52.2%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $1.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001213900-26-035707.Revenue: $3.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure59.8%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $2.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001213900-26-035707.Revenue: $3.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure
Operating margin%(4038.1%)Operating margin, period not labelled, twelve months to 2021-12-31. operating income / revenueOperating income: −$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-10, accession 0001575872-23-000346.Revenue: $160.0k. XBRL concept us-gaap:Revenues. 10-K filed 2023-03-10, accession 0001575872-23-000346.Report this figure(2709.8%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$18.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-29, accession 0001213900-24-028010.Revenue: $691.0k. XBRL concept us-gaap:Revenues. 10-K filed 2024-03-29, accession 0001213900-24-028010.Report this figure(537.1%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$15.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-26, accession 0001013762-25-002734.Revenue: $2.9m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-26, accession 0001013762-25-002734.Report this figure(420.1%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035707.Revenue: $3.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure(324.3%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$12.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035707.Revenue: $3.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure
Net margin%(4405.0%)Net margin, period not labelled, twelve months to 2021-12-31. net income / revenueNet income: −$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-10, accession 0001575872-23-000346.Revenue: $160.0k. XBRL concept us-gaap:Revenues. 10-K filed 2023-03-10, accession 0001575872-23-000346.Report this figure(2737.6%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$18.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-29, accession 0001213900-24-028010.Revenue: $691.0k. XBRL concept us-gaap:Revenues. 10-K filed 2024-03-29, accession 0001213900-24-028010.Report this figure(532.1%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$15.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-26, accession 0001013762-25-002734.Revenue: $2.9m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-26, accession 0001013762-25-002734.Report this figure(417.2%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$13.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035707.Revenue: $3.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure(318.4%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$12.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001213900-26-035707.Revenue: $3.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure
Diluted EPS$ per share(7.81)Diluted EPS, period not labelled, twelve months to 2021-12-31−$7.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-10, accession 0001575872-23-000346.Report this figure(23.62)Diluted EPS, FY2022, twelve months to 2022-12-31−$23.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-29, accession 0001213900-24-028010.Report this figure(68.64)Diluted EPS, FY2023, twelve months to 2023-12-31−$68.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-26, accession 0001013762-25-002734.Report this figure(11.26)Diluted EPS, FY2024, twelve months to 2024-12-31−$11.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure(1.70)Diluted EPS, FY2025, twelve months to 2025-12-31−$1.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure
Free cash flow$m(4.4)Free cash flow, period not labelled, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-10, accession 0001575872-23-000346.Capital expenditure: $102.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-10, accession 0001575872-23-000346.Report this figure(12.9)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-29, accession 0001213900-24-028010.Capital expenditure: $847.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-10, accession 0001575872-23-000346.Report this figure(12.5)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-26, accession 0001013762-25-002734.Capital expenditure: $361.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-26, accession 0001013762-25-002734.Report this figure(10.1)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001213900-26-035707.Capital expenditure: $186.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure(11.0)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001213900-26-035707.Capital expenditure: $273.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001213900-26-035707.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Tenon Medical, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Focus Partners Wealth2026-06-30$51.0k4,720,000Added+4,658,113
Clear Street Group Inc.2026-06-30$10.3k952,794Reduced−100
Spectrum Asset Management, Inc. (NB/CA)2026-06-30$7.3k679,420Unchanged
HEIGHTS CAPITAL MANAGEMENT, INC2026-06-30$1.5k140,236Unchanged
AQR CAPITAL MANAGEMENT LLC2026-06-30$1.4k131,000Unchanged
CITADEL ADVISORS LLC2026-06-30$83970,499Reduced−2,222
ARMISTICE CAPITAL, LLC2026-06-30$24022,250Unchanged
GTS SECURITIES LLC2026-06-30$23121,044Reduced−100
UBS Group AG2026-06-30$5499Added+399

Recent filings

All 300 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Tenon Medical, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-2221:02 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-26-111740
2026-09-1621:23 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-26-100596
2026-09-0912:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-26-098232
2026-08-3119:40 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-26-095686
2026-08-2619:30 ET8-K/A1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-26-093926
2026-08-2417:23 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-26-092944
2026-08-1321:20 ET10-QQuarterly reportPeriod 2026-06-300001213900-26-089258
2026-08-1320:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-26-089138
2026-08-1021:26 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-26-087352
2026-07-2420:45 ET8-K5.07 Shareholder vote results0001213900-26-081438

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 27, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1560293
Tickers
TNON, TNONW
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.